Protagonist Therapeutics logo
Protagonist Therapeutics PTGX
$ 46.12 10.72%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Protagonist Therapeutics EV/EBITDA Ratio 2011-2024 | PTGX

Annual EV/EBITDA Ratio Protagonist Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-10.1 -10.7 -2.14 -2.36 -7.54 -3.13 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.14 -10.7 -6